Variant report

Variant	nsv1056372
Chromosome Location	chr19:41352371-41392885
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:372)
CpG islands
(count:673)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:372 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
2	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
3	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
4	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
5	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
6	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
7	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
8	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
9	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
10	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
11	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
12	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
13	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
15	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
16	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
17	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
18	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
19	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
20	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
21	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
22	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
23	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
24	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
25	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
26	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
27	CEBPD	chr19:41392214-41392550	K562	blood:	n/a	n/a
28	CTCF	chr19:41359824-41359874	LNCaP	prostate:	n/a	n/a
29	CTCF	chr19:41354547-41354639	HUVEC	blood vessel:	n/a	n/a
30	CTCF	chr19:41364147-41364298	K562	blood:	n/a	n/a
31	CTCF	chr19:41354520-41354670	HMF	breast:	n/a	n/a
32	CTCF	chr19:41354520-41354670	AG09309	skin:	n/a	n/a
33	CTCF	chr19:41354500-41354650	WERI-Rb-1	eye:	n/a	n/a
34	CTCF	chr19:41368340-41368490	NHDF-neo	bronchial:	n/a	n/a
35	CTCF	chr19:41367560-41367710	K562	blood:	n/a	n/a
36	CTCF	chr19:41368300-41368450	MCF-7	breast:	n/a	n/a
37	CTCF	chr19:41354580-41354730	HVMF	connective:	n/a	chr19:41354699-41354709
38	CTCF	chr19:41354500-41354650	AG09319	gingival:	n/a	n/a
39	CTCF	chr19:41354359-41354806	A549	lung:	n/a	chr19:41354699-41354709
40	CTCF	chr19:41360494-41360547	Kidney_OC	kidney:	n/a	n/a
41	CTCF	chr19:41354459-41354759	K562	blood:	n/a	chr19:41354699-41354709
42	CTCF	chr19:41354521-41354704	Lung_OC	lung:	n/a	n/a
43	CTCF	chr19:41354505-41354668	Fibrobl	skin:	n/a	n/a
44	CTCF	chr19:41354500-41354650	A549	lung:	n/a	n/a
45	CTCF	chr19:41368300-41368450	AG04450	lung:	n/a	n/a
46	CTCF	chr19:41364037-41364460	MCF-7	breast:	n/a	n/a
47	CTCF	chr19:41364176-41364245	MCF-7	breast:	n/a	n/a
48	CTCF	chr19:41364080-41364230	A549	lung:	n/a	n/a
49	CTCF	chr19:41354802-41355008	Lung_OC	lung:	n/a	n/a
50	CTCF	chr19:41368380-41368530	HEK293	kidney:	n/a	n/a

(count:673 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41354682-41354732	SK-N-SH	brain:	n/a
2	chr19:41386507-41386557	Hela-S3	cervix:	n/a
3	chr19:41354682-41354732	SK-N-SH	brain:	n/a
4	chr19:41386507-41386557	Hela-S3	cervix:	n/a
5	chr19:41354142-41354192	HRE	kidney:	n/a
6	chr19:41386507-41386557	SK-N-SH	brain:	n/a
7	chr19:41385865-41385915	LNCaP	prostate:	n/a
8	chr19:41388384-41388434	PFSK-1	brain:	n/a
9	chr19:41354682-41354732	PFSK-1	brain:	n/a
10	chr19:41386507-41386557	ProgFib	skin:	n/a
11	chr19:41386507-41386557	NHBE	bronchial:	n/a
12	chr19:41389684-41389734	HepG2	liver:	n/a
13	chr19:41386441-41386491	AG10803	skin:	n/a
14	chr19:41389684-41389734	HCT-116	colon:	n/a
15	chr19:41388384-41388434	MCF-7	breast:	n/a
16	chr19:41354682-41354732	LNCaP	prostate:	n/a
17	chr19:41388384-41388434	AoSMC	blood vessel:	n/a
18	chr19:41383654-41383704	SK-N-SH	brain:	n/a
19	chr19:41388384-41388434	Hepatocyte	liver:	n/a
20	chr19:41354682-41354732	IMR90	lung:	fetal
21	chr19:41354553-41354603	SK-N-SH_RA	brain:	n/a
22	chr19:41354682-41354732	NH-A	brain:	n/a
23	chr19:41385865-41385915	PFSK-1	brain:	n/a
24	chr19:41389684-41389734	HUVEC	blood vessel:	n/a
25	chr19:41354553-41354603	GM12878	blood:	n/a
26	chr19:41385865-41385915	CMK	blood:	n/a
27	chr19:41354553-41354603	HepG2	liver:	n/a
28	chr19:41354553-41354603	NT2-D1	testis:	n/a
29	chr19:41388384-41388434	SAEC	small airway:	n/a
30	chr19:41385865-41385915	Caco-2	colon:	n/a
31	chr19:41388232-41388282	SK-N-SH_RA	brain:	n/a
32	chr19:41388232-41388282	K562	blood:	n/a
33	chr19:41386507-41386557	HCF	heart:	n/a
34	chr19:41354553-41354603	HCF	heart:	n/a
35	chr19:41386507-41386557	HIPEpiC	eye:	n/a
36	chr19:41354142-41354192	AG10803	skin:	n/a
37	chr19:41354142-41354192	ProgFib	skin:	n/a
38	chr19:41354142-41354192	HEK293	kidney:	embryo
39	chr19:41388384-41388434	HCM	heart:	n/a
40	chr19:41383654-41383704	GM12892	blood:	n/a
41	chr19:41354553-41354603	PANC-1	pancreas:	n/a
42	chr19:41388384-41388434	HRCEpiC	kidney:	n/a
43	chr19:41354682-41354732	PrEC	prostate:	n/a
44	chr19:41386507-41386557	Hepatocyte	liver:	n/a
45	chr19:41354682-41354732	AoSMC	blood vessel:	n/a
46	chr19:41355973-41356023	SK-N-SH_RA	brain:	n/a
47	chr19:41386507-41386557	SK-N-MC	brain:	n/a
48	chr19:41388384-41388434	NH-A	brain:	n/a
49	chr19:41354682-41354732	AG10803	skin:	n/a
50	chr19:41388232-41388282	PrEC	prostate:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
2	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:
3	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
4	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:

No data

Variant related genes	Relation type
CYP2G1P	TF binding region
CYP2A6	TF binding region
CYP2A7	TF binding region
CYP2G1P	CpG island
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000105245	chromatin interactions
ENSG00000262246	chromatin interactions
ENSG00000103423	chromatin interactions

Extended variants
information (count: 2165 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:2165 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs539876412	chr19:41352372-41352373	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs561338846	chr19:41352373-41352374	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs529234878	chr19:41352426-41352427	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs550606305	chr19:41352433-41352434	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs562763156	chr19:41352451-41352452	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs72549442	chr19:41352460-41352461	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs186832592	chr19:41352462-41352463	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs373351065	chr19:41352467-41352468	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs551576716	chr19:41352501-41352502	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs570989597	chr19:41352538-41352539	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs535108140	chr19:41352544-41352545	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs547061178	chr19:41352557-41352558	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs568362425	chr19:41352574-41352575	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs535800169	chr19:41352575-41352576	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs557383130	chr19:41352606-41352607	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs575865729	chr19:41352617-41352618	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs539671336	chr19:41352623-41352624	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs553581029	chr19:41352648-41352649	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs572642295	chr19:41352673-41352674	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs191677607	chr19:41352680-41352681	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs377172256	chr19:41352681-41352682	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs572110543	chr19:41352726-41352727	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs561775706	chr19:41352750-41352751	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs372132635	chr19:41352756-41352757	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs376697000	chr19:41352758-41352759	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs546098110	chr19:41352759-41352760	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs4079369	chr19:41352762-41352763	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs544162826	chr19:41352783-41352784	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs111869995	chr19:41352786-41352787	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs58062848	chr19:41352789-41352790	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs139639589	chr19:41352790-41352791	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs551638939	chr19:41352795-41352796	Weak transcription Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs560382680	chr19:41352802-41352803	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs55805386	chr19:41352807-41352808	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs147901382	chr19:41352810-41352811	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs527434101	chr19:41352816-41352817	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs140471703	chr19:41352817-41352818	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs372458720	chr19:41352837-41352838	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs58720852	chr19:41352838-41352839	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs1809811	chr19:41352840-41352841	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs145157460	chr19:41352842-41352843	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs533216061	chr19:41352845-41352846	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs374784083	chr19:41352858-41352859	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs149223328	chr19:41352875-41352876	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs550929967	chr19:41352882-41352883	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs145148721	chr19:41352884-41352885	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs369120926	chr19:41352890-41352891	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs138978736	chr19:41352896-41352897	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs539734599	chr19:41352901-41352902	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs3891219	chr19:41352912-41352913	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:281 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41349800-41353800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:41350000-41352600	Weak transcription	Lung	lung
3	chr19:41350000-41353000	Strong transcription	Liver	Liver
4	chr19:41350600-41354400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
5	chr19:41350800-41354400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
6	chr19:41351000-41354600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
7	chr19:41351200-41354400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
8	chr19:41351200-41354400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
9	chr19:41351400-41354200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
10	chr19:41352800-41353000	Enhancers	Lung	lung
11	chr19:41352800-41354400	Weak transcription	Pancreas	Pancrea
12	chr19:41353000-41353600	Weak transcription	Lung	lung
13	chr19:41353000-41354000	Weak transcription	Liver	Liver
14	chr19:41353600-41354800	Enhancers	Lung	lung
15	chr19:41353800-41354000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
16	chr19:41353800-41354200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr19:41353800-41354200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr19:41353800-41354800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
19	chr19:41354000-41354200	Enhancers	Liver	Liver
20	chr19:41354000-41354800	Enhancers	Spleen	Spleen
21	chr19:41354200-41354400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
22	chr19:41354200-41354400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
23	chr19:41354200-41354400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
24	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr19:41354200-41354400	Enhancers	Ovary	ovary
27	chr19:41354200-41354600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
28	chr19:41354200-41354600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr19:41354200-41354600	Flanking Active TSS	Liver	Liver
30	chr19:41354200-41354800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
31	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
32	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
33	chr19:41354200-41354800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
34	chr19:41354200-41355000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
35	chr19:41354200-41355000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
36	chr19:41354400-41354600	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
37	chr19:41354400-41354600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
38	chr19:41354400-41354600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
39	chr19:41354400-41354600	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
40	chr19:41354400-41354600	Bivalent Enhancer	Fetal Brain Male	brain
41	chr19:41354400-41354600	Flanking Active TSS	Ovary	ovary
42	chr19:41354400-41354600	Enhancers	Rectal Smooth Muscle	rectum
43	chr19:41354400-41354600	Enhancers	Right Ventricle	heart
44	chr19:41354400-41354600	Bivalent Enhancer	Stomach Mucosa	stomach
45	chr19:41354400-41354800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
46	chr19:41354400-41354800	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
47	chr19:41354400-41354800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
48	chr19:41354400-41354800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
49	chr19:41354400-41354800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
50	chr19:41354400-41354800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links